In Vitro Activity of a Novel Diaminopyrimidine Compound, Iclaprim, against Chlamydia trachomatis and C. pneumoniae

The in vitro activities of iclaprim, a novel dihydrofolate reductase inhibitor, azithromycin, and levofloxacin were tested against 10 strains of Chlamydia trachomatis and 10 isolates of Chlamydia pneumoniae. For C. trachomatis and C. pneumoniae, the iclaprim MIC and minimal bactericidal concentratio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kohlhoff, S. A., Roblin, P. M., Reznik, T., Hawser, S., Islam, K., Hammerschlag, M. R.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2004
Matèries:
Susceptibility
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC400585/
https://ncbi.nlm.nih.gov/pubmed/15105151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.5.1885-1886.2004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars